Vor Biopharma Inc. (VOR) NASDAQ
$5.30 -0.03 (-0.56%)
Market Cap: $356.88M
As of 06/07/23 04:00 PM EDT. Market closed.
Vor Biopharma Inc. (VOR)
NASDAQ
$5.30
-0.03 (-0.56%)
Market Cap: $356.88M
As of 06/07/23 04:00 PM EDT. Market closed.
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to ... read more
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells. read less
Open in: 
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| ANG ROBERT | President and CEO | May 08, 2023 | Option Exercise | $4.14 | 2,361 | 9,775 | 698,304 | May 10, 2023, 04:19 PM |
| Chakraborty Tirtha | Chief Scientific Officer | May 08, 2023 | Option Exercise | $4.14 | 875 | 3,622 | 141,279 | May 10, 2023, 04:18 PM |
| Jorgensen Nathan D. | Chief Financial Officer | May 08, 2023 | Option Exercise | $4.14 | 834 | 3,453 | 153,625 | May 10, 2023, 04:16 PM |
| Attar Eyal C. | Chief Medical Officer | May 08, 2023 | Option Exercise | $4.14 | 969 | 4,012 | 53,531 | May 10, 2023, 04:14 PM |
| ANG ROBERT | President and CEO | Mar 01, 2023 | Option Exercise | $5.51 | 12,657 | 69,740 | 700,665 | Mar 02, 2023, 06:39 PM |
| Chakraborty Tirtha | Chief Scientific Officer | Mar 01, 2023 | Option Exercise | $5.51 | 5,576 | 30,724 | 142,154 | Mar 02, 2023, 06:37 PM |
| Jorgensen Nathan D. | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $5.51 | 6,310 | 34,768 | 154,459 | Mar 02, 2023, 06:35 PM |
| Jorgensen Nathan D. | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $5.51 | 6,310 | 34,768 | 154,459 | Mar 02, 2023, 06:35 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Dec 09, 2022 | Option Exercise | $4.30 | 11,627,907 | 50,000,002 | 20,923,554 | Dec 09, 2022, 04:32 PM |
| 5AM Ventures VI, L.P. | 10% Owner | Nov 16, 2021 | Sale | $15.30 | 330,706 | 5,059,802 | 4,595,089 | Nov 18, 2021, 08:14 PM |
| PARMAR KUSH | Director | Nov 16, 2021 | Sale | $15.30 | 330,706 | 5,059,802 | 4,595,089 | Nov 18, 2021, 08:10 PM |
| Chakraborty Tirtha | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $1.36 | 17,446 | 23,727 | 20,980 | Aug 19, 2021, 04:02 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Feb 09, 2021 | Buy | $18.00 | 2,979,566 | 53,632,188 | 8,297,265 | Feb 09, 2021, 06:25 PM |
| 5AM Ventures VI, L.P. | 10% Owner | Feb 09, 2021 | Buy | $18.00 | 555,555 | 9,999,990 | 4,833,959 | Feb 09, 2021, 06:03 PM |
| PARMAR KUSH | Director | Feb 09, 2021 | Buy | $18.00 | 555,555 | 9,999,990 | 4,833,959 | Feb 09, 2021, 05:15 PM |
| Owner | Relationship | Date | Value($) |
| ANG ROBERT | President and CEO | 05/08/2023 | 9,775 |
| Chakraborty Tirtha | Chief Scientific Officer | 05/08/2023 | 3,622 |
| Jorgensen Nathan D. | Chief Financial Officer | 05/08/2023 | 3,453 |
| Attar Eyal C. | Chief Medical Officer | 05/08/2023 | 4,012 |
| ANG ROBERT | President and CEO | 03/01/2023 | 69,740 |
| Chakraborty Tirtha | Chief Scientific Officer | 03/01/2023 | 30,724 |
| Jorgensen Nathan D. | Chief Financial Officer | 03/01/2023 | 34,768 |
| Jorgensen Nathan D. | Chief Financial Officer | 03/01/2023 | 34,768 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 12/09/2022 | 50,000,002 |
| 5AM Ventures VI, L.P. | 10% Owner | 11/16/2021 | 5,059,802 |
| PARMAR KUSH | Director | 11/16/2021 | 5,059,802 |
| Chakraborty Tirtha | Chief Scientific Officer | 08/17/2021 | 23,727 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 02/09/2021 | 53,632,188 |
| 5AM Ventures VI, L.P. | 10% Owner | 02/09/2021 | 9,999,990 |
| PARMAR KUSH | Director | 02/09/2021 | 9,999,990 |
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 22,748,880 | 2.77% | No change | Other |
| BAKER BROS. ADVISORS LP | 633,848 | 0.02% | -56.76% | Other |
| BLACKROCK INC. | 467,598 | 0.00007% | 97.07% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 315,947 | 0.00022% | 89.46% | Other |
| D. E. SHAW & CO., INC. | 11,478 | 0.00007% | -77.45% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 28,400 | 0.0002% | -38.22% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 12,627 | 0.00017% | New | Event Driven |
Period of Report: 12/31/2022
10-K/10-Q Filings: View